Montelukast Sodium

MK0476 Study in Adult Patients With Perennial Allergic Rhinitis (0476-397)(COMPLETED)

An Investigational Drug Study to Treat Respiratory Symptoms Associated With Respiratory Syncytial Virus (RSV) Bronchiolitis (0476-272)

An Approved Drug to Study a New Indication for Allergic Rhinitis (0476-327)

Investigation of Intravenous (IV) Administration of an Approved Drug (MK-0476, Montelukast Sodium) for Acute Asthma (MK-0476-288)

The Singulair® add-on Study Effectiveness of Adding Montelukast to Inhaled Corticosteroids in Adult Subjects With Uncontrolled Asthma (0476-384)

Singulair(R) In Asthma And Allergic Rhinitis (0476-383)

Montelukast in Mild Asthmatic Children With Allergic Rhinitis (0476-367)

Pediatric ACTION3 (Identify, Treat, Control): Effectiveness of Adding Montelukast in Pediatric Subjects With Uncontrolled Asthma (0476-385)

Two Investigational Drugs in the Prevention of Airway Constriction Brought on by Exercise in Participants With Asthma (0476-911)

Intermittent and Daily Dosing for Episodic (Periodic) Asthma (0476-302)(COMPLETED)

A Study of an Intravenous Drug in Pediatric Patients With Acute Asthma (0476-301)

Montelukast Asthmatic Smoker Study (0476-332)(COMPLETED)

Exercise Induced Bronchoconstriction (0476-359)

A Study of Montelukast (MK-0476) Compared With Fluticasone in Pediatric Participants With Chronic Asthma (MK-0476-303)

The Clinical Effect of MK0476 With Concomitant Administration of and Removal of Inhaled Beclomethasone in Asthmatic Patients (0476-029)

Extended Safety Study of Montelukast in Infants and Young Children With Chronic Asthma (0476-232)

Montelukast in Pediatric Patients Aged 6 to 24 Months With Asthma--Safety Study (0476-176)

A Study Comparing Montelukast With Placebo in Children With Seasonal Allergic Rhinitis (0476-219)(COMPLETED)

Montelukast in Perennial Allergic Rhinitis - 2001-2002 Study (0476-246)

Montelukast in Seasonal Allergic Rhinitis - Spring 2001 Study (0476-235)